IRIX
IRIDEXCNasdaq / Health Care Equipment & Services
Last Price
At close
2026-07-23
Current thesis
IRIDEX exited 2025 with its strongest quarter of the year, 16% Q4 revenue growth, 22% lower full-year opex, positive 2025 adjusted EBITDA, 2026 revenue guidance of $51 million to $53 million, and a stated goal of positive operating cash flow; at roughly $21 million market cap, that leaves meaningful upside if execution continues [#8-K-2026-03-26].
Posture
Mixed
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite.
What can break
Gross-margin pressure from tariffs, manufacturing costs, and inventory dynamics could offset revenue gains.
Momentum
77
Value
37
Sentiment
54
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $0.90 · Bull $1.60 · Bear $0.45
Data freshness
Prices
As of 2026-07-23
Fundamentals
As of 2026-07-23 • Vendor: Data Vendor v1
Scores
As of 2026-07-23 • Model: HYBRID_IC_RP
AI Memo
As of 2026-04-15 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-07-23
Investment thesis
As of 2026-07-23
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $2.75
Why
Momentum77 · Δ7d -
Value37 · Δ7d -0.0
Sentiment54 · Δ7d -
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Lead driver: Momentum · See technicals
Momentum
77
26% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
37
39% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+0.1
Sentiment
54
34% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade C. Momentum 77.3 / Value 36.5 / Sentiment 54.5
Fundamentals (TTM)As of 2026-07-23
Fundamentals (TTM)
As of 2026-07-23
Market Cap
$16.05M
Beta
0.70
Shares Out
17.41M
P/E (TTM) · Derived
-3.5
P/S (TTM)
0.41
P/FCF (TTM) · Derived
-6.23
Rev YoY
-0.8%
EPS YoY
-69.9%
Gross Margin
+35.4%
Op Margin
-6.0%
Net Debt
-$1.5M
Current Ratio
1.92
As of 2026-07-23 • Updated nightlySource: Internal modelMethodology